Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vormittag L et al. - In a study to assess the role of CA 19-9 in predicting early failure of first-line chemotherapy in advanced pancreatic cancer (PCa), these results suggest that early CA 19-9 measurements are weakly associated with disease progression rather than survival in pts with advanced PCa receiving palliative chemotherapy. In view of a possible tumor marker flare, values after the first mo of therapy must be interpreted with caution.

Methods

Results


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address